Komori
Takakita (6325) · RiskMaterialised

Risk of fluctuations in the market prices of investment securities

First written in FY2017. 13 of 23 entries say "Restated". Latest entry: FY2025.

23entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY2019-Q1RestatedFY2021-Q1 – FY2024-Q32017: 320172018: 320182019: 420192020: 420202021: 420212022: 220222023: 020232024: 220242025: 12025
Same theme, other companies
Risk from Changes in the Market Prices of Held Financial InstrumentsA theme 345 companies write about · 344 as a headwind · 2 as a tailwind

Takakita moved to the "Worse" side of this theme in 2019, 1 year before the typical company in this theme (2020).

The whole theme swung hardest in 2019: 55 of 137 companies on the "Worse" side.

37 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 347 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025MaterialisedAnnual report

    「In the fiscal year, the company recognized impairment losses of ¥17.460 million on securities, comprising ¥17.230 million on shares other than shares without market prices classified as other securities, ¥100 thousand on shares without market prices classified as other securities, and ¥130 thousand on equity investments.」

    The market price fluctuation and decline-in-value risks relating to investment securities and other assets materialized as impairment losses of ¥17.460 million.
  2. FY2025-H1MaterialisedAnnual report

    「Impairment loss on investment securities - 20,007」

    The company recorded an impairment loss on investment securities of ¥20.007 million during the interim accounting period, meaning that the market price fluctuation risk materialized as an impairment loss.
  3. FY2024-Q3RestatedAnnual report

    「During the nine months ended the third quarter, there were no new business or other risks and no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The Company stated that there had been no material changes in the risk of fluctuations in the market prices of investment securities.
  4. FY2023-Q2RestatedAnnual report

    「During the cumulative second-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」

    The company states that there have been no material changes in the market price fluctuation risk relating to investment securities.
  5. FY2022-Q3RestatedAnnual report

    「During the nine months ended the third quarter, there were no new business or other risks and no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no material changes in the market price fluctuation risk relating to investment securities.
  6. FY2022-Q2RestatedAnnual report

    「During the cumulative second-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」

    The company states that there have been no material changes in the market price fluctuation risk relating to investment securities.
  7. FY2022-Q1RestatedAnnual report

    「During the cumulative first quarter, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes in the market price fluctuation risk relating to investment securities.
  8. FY2021Decrease in valuation lossesAnnual report

    「In the fiscal year, the company recognized impairment losses of ¥2.769 million on securities, comprising ¥2.769 million on shares classified as other securities.」

    An impairment loss on investment securities was recorded, but it decreased from ¥12.682 million in the previous fiscal year to ¥2.769 million.
  9. FY2021-Q3Decrease in valuation lossesAnnual report

    「Impairment loss on investment securities 9,692 854」

    The company recorded an impairment loss on investment securities of ¥854 thousand, meaning that the market price fluctuation risk continued to be reflected in actual results. This was down from ¥9.692 million in the same period of the previous year.
  10. FY2021-Q2RestatedAnnual report

    「During the cumulative second quarter, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes in the market price fluctuation risk relating to investment securities.
  11. FY2021-Q1RestatedAnnual report

    「During the six months ended [current first quarter], there was no emergence of new business or other risks, nor any material change in the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes in the market price fluctuation risk relating to investment securities.
  12. FY2020MaterialisedAnnual report

    「In the fiscal year, the company recognized impairment losses of ¥12.682 million on securities, comprising ¥12.682 million on shares classified as other securities.」

    The market price fluctuation risk relating to investment securities materialized as an impairment loss of ¥12.682 million in the fiscal year.
  13. FY2020-Q3MaterialisedAnnual report

    「Impairment loss on investment securities 42,844 9,692」

    The company recorded an impairment loss on investment securities of ¥9.692 million during the cumulative third quarter period, meaning that the market price fluctuation risk materialized as an impairment loss. This was down from ¥42.844 million in the same period of the previous year.
  14. FY2020-Q2MaterialisedAnnual report

    「Impairment loss on investment securities - 11,280」

    The company recorded an impairment loss on investment securities of ¥11.280 million during the cumulative second quarter period, meaning that the market price fluctuation risk materialized as an impairment loss.
  15. FY2020-Q1RestatedAnnual report

    「During the six months ended [current first quarter], there was no emergence of new business or other risks, nor any material change in the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes in business and other risks, including the risk of market price fluctuations relating to investment securities.
  16. FY2019MaterialisedAnnual report

    「Impairment loss on investment securities ¥77.124 million」

    The market price fluctuation risk relating to investment securities materialized as an impairment loss of ¥77.124 million in the fiscal year.
  17. FY2019-Q3MaterialisedAnnual report

    「Impairment loss on investment securities - 42,844」

    The company recorded an impairment loss on investment securities of ¥42.844 million during the cumulative third quarter period, meaning that the market price fluctuation risk relating to investment securities materialized as an impairment loss.
  18. FY2019-Q1RestatedAnnual report

    「During the six months ended [current first quarter], there was no emergence of new business or other risks, nor any material change in the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes in business and other risks, including the risk of market price fluctuations relating to investment securities.
  19. FY2018RestatedAnnual report

    「Shares classified as investment securities are exposed to the risk of fluctuations in market prices, but are primarily shares in companies with which the company has business relationships. The company regularly monitors their fair value and the financial condition of the issuers, which are business partners, and continuously reviews its holdings in light of market conditions and its relationships with business partners.」

    The company reiterates the market price fluctuation risk relating to investment securities and its ongoing review based on fair value, issuer conditions and business relationships.
  20. FY2018-Q3RestatedAnnual report

    「During the nine months ended the third quarter, there were no new business or other risks and no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no material changes to the business and other risks, including the risk of fluctuations in the market prices of investment securities.
  21. FY2018-Q2RestatedAnnual report

    「During the cumulative second-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」

    The company states that there have been no material changes to the business and other risks, including the risk of fluctuations in the market prices of investment securities.
  22. FY2018-Q1RestatedAnnual report

    「During the six months ended [current first quarter], there was no emergence of new business or other risks, nor any material change in the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes to the business and other risks, including the risk of fluctuations in the market prices of investment securities.
  23. FY2017First statedAnnual report

    「Shares classified as investment securities are exposed to the risk of fluctuations in market prices, but are primarily shares in companies with which the company has business relationships.」

    The company discloses the risk of market price fluctuations relating to investment securities held for business relationship purposes.
Moved together

"Fluctuations in Agricultural Machinery Demand, Including Rice Prices and the Chinese Market" moved the same way as this thread, in the same document, in 7 of its 23 moves.

764332★123456
  1. ★This thread
  2. 1Fluctuations in Agricultural Machinery Demand, Including Rice Prices and the Chinese Market7×
  3. 2Risks from shifts in agricultural policy and structure6×
  4. 3Expansion in Overseas Markets and Development of Sales Channels4×
  5. 4Rising Raw Material Prices3×
  6. 5Seasonality and Weather Variability Risks in the Agricultural Machinery Business3×
  7. 6Dependence on Specific Customers2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Takakita's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.